Cysal is an innovative biotechnology company based in Germany working in close partnership with the University of Münster. Our key interest is harnessing microbial metabolic diversity for the development of novel industrial fermentation technologies and products.
Cysal is using microbial metabolic diversity for the development of novel fermentation technologies and products. Our current focus is the biotechnological production of dipeptides at an industrial scale and the development of novel applications based on these dipeptides.
Advanced biotechnological fermentation strategies are increasingly replacing chemical approaches for the production of speciality and base commodities. This trend is set to continue with the increased demand for more sustainable alternatives to traditional industrial processes.
Cysal is an innovative biotechnology company with a focus on developing, optimizing, and licensing fermentation technology solutions and novel applications for biopolymers and low-molecular weight compounds such as dipeptides.
Our own expertise in industrial biotechnology and our large and robust network of collaboration partners and institutions within Germany and abroad enable us to deliver solutions and products tailor-made to perfectly meet the requirements of our customers.